- Home
- CISS vs EYEN Comparison
CISS vs EYEN Comparison
Compare CISS & EYEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISS
- EYEN
- Stock Information
- Founded
- CISS 2022
- EYEN 2014
- Country
- CISS Greece
- EYEN United States
- Employees
- CISS N/A
- EYEN N/A
- Industry
- CISS Marine Transportation
- EYEN Biotechnology: Pharmaceutical Preparations
- Sector
- CISS Consumer Discretionary
- EYEN Health Care
- Exchange
- CISS Nasdaq
- EYEN Nasdaq
- Market Cap
- CISS 2.4M
- EYEN 2.0M
- IPO Year
- CISS N/A
- EYEN 2018
- Fundamental
- Price
- CISS $3.90
- EYEN $1.09
- Analyst Decision
- CISS
- EYEN Hold
- Analyst Count
- CISS 0
- EYEN 4
- Target Price
- CISS N/A
- EYEN $2.00
- AVG Volume (30 Days)
- CISS 62.5K
- EYEN 45.2K
- Earning Date
- CISS 05-27-2025
- EYEN 04-15-2025
- Dividend Yield
- CISS N/A
- EYEN N/A
- EPS Growth
- CISS N/A
- EYEN N/A
- EPS
- CISS N/A
- EYEN N/A
- Revenue
- CISS $42,296,101.00
- EYEN $57,336.00
- Revenue This Year
- CISS N/A
- EYEN $7,680.45
- Revenue Next Year
- CISS N/A
- EYEN $315.38
- P/E Ratio
- CISS N/A
- EYEN N/A
- Revenue Growth
- CISS 47.17
- EYEN 1414.02
- 52 Week Low
- CISS $2.85
- EYEN $0.85
- 52 Week High
- CISS $29.40
- EYEN $124.80
- Technical
- Relative Strength Index (RSI)
- CISS 50.21
- EYEN 39.27
- Support Level
- CISS $3.20
- EYEN $1.02
- Resistance Level
- CISS $3.58
- EYEN $1.18
- Average True Range (ATR)
- CISS 0.37
- EYEN 0.09
- MACD
- CISS 0.10
- EYEN 0.06
- Stochastic Oscillator
- CISS 70.50
- EYEN 72.73
About CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.